Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03978624
Title Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

bladder urothelial carcinoma

Therapies

Pembrolizumab

Entinostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lineberger Comprehensive Cancer Center Recruiting Chapel Hill North Carolina 27599 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field